Psychiatry Investig.  2009 Dec;6(4):264-271.

Depressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study

Affiliations
  • 1Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea. kwonjs@snu.ac.kr
  • 2Department of Psychiatry, Seoul National University College of Medicine, Boramae Hospital, Seoul, Korea.
  • 3Department of Radiology, National Medical Center, Seoul, Korea.
  • 4Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon, Korea.
  • 5Department of Biomedical Engineering, Hanyang University, Seoul, Korea.
  • 6Interdisciplinary Program in Brain Science, Seoul National University, Seoul, Korea.

Abstract


OBJECTIVE
Recent neuroimaging studies have suggested that brain changes occur in subjects at ultra-high risk (UHR) for psychosis while experiencing prodromal symptoms, among which depression may increase the risk of developing a psychotic disorder. The goal of this study is to examine brain metabolite levels in the anterior cingulate cortex, the left dorsolateral prefrontal cortex and the left thalamus in subjects at UHR for psychosis and to compare brain metabolite levels between the UHR subjects with comorbid major depressive disorder and healthy controls. METHODS: Proton magnetic resonance spectroscopy was used to examine brain metabolite levels. Twenty UHR subjects and 20 age- and intelligence quotient (IQ)-matched healthy controls were included in this study. RESULTS: Overall, no significant differences were observed in any metabolite between the UHR and healthy control group. However, UHR subjects with major depressive disorder showed significantly higher myo-inositol (Ins) levels in the left thalamus, compared to the healthy control. CONCLUSION: Our results demonstrate that increased thalamic Ins level is associated with prodromal depressive symptoms. Further longitudinal follow-up studies with larger UHR sample sizes are required to investigate the function of Ins concentrations as a biomarker of vulnerability to psychosis.

Keyword

Depression; Magnetic resonance spectroscopy; Schizophrenia; Ultra-high risk

MeSH Terms

Brain
Depression
Depressive Disorder, Major
Gyrus Cinguli
Intelligence
Magnetic Resonance Spectroscopy
Neuroimaging
Prefrontal Cortex
Prodromal Symptoms
Protons
Psychotic Disorders
Sample Size
Schizophrenia
Thalamus
Protons
Full Text Links
  • PI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr